In contrast, pretreatment of PAO1 with PAA before challenging A549 increased the A549 cell viability in a dosage-dependent manner, highly similar to the controls in which various amount of PAA were added to A549 shortly prior to infection with untreated PAO1 (Fig. 5). The gene discussed is SMOX; the disease is infection.